<DOC>
	<DOCNO>NCT03056274</DOCNO>
	<brief_summary>This pilot study aim compare effect metformin versus ursodeoxycholic acid woman intrahepatic cholestasis pregnancy . The study conduct three NHS hospital site , 18 month period .</brief_summary>
	<brief_title>Metformin Intrahepatic Cholestasis Pregnancy</brief_title>
	<detailed_description>Intrahepatic cholestasis condition affect pregnant woman . It characterise itch , usually third trim pregnancy associate increase liver enzymes bile salt . This associated maternal neonatal morbidity , rarely perinatal mortality . The investigator propose assess compare effect Metformin versus Ursodeoxycholic acid lower liver enzymes bile salt , improve maternal morbidity improve neonatal outcomes . This study pilot study conduct 3 NHS hospital sit patient randomly assign receive either Metformin Ursodeoxycholic acid . There 20 patient arm . Recruitment commence February 2017 run 18 month period .</detailed_description>
	<mesh_term>Cholestasis</mesh_term>
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Cholestasis , Intrahepatic</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>1 . 20+0 40 week ' gestation day randomisation 2 . Itching raise serum bile acid upper limit normal 3 . Normal anomaly scan 20 week 4 . Aged 18 year 5 . Able give write informed consent 6 . No known preexisting liver disease 1 . Decision already make delivery within next 48 hour 2 . Known allergy component ursodeoxycholic acid metformin tablets 3 . Patients already metformin condition</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Metformin</keyword>
	<keyword>Ursodeoxycholic acid</keyword>
	<keyword>Outcomes</keyword>
</DOC>